Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 38, 2024 - Issue 11
78
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Chemical composition and anti-angiogenic activity of the essential oil from Blumea eriantha D.C.

&
Pages 1918-1923 | Received 15 Feb 2023, Accepted 18 Jun 2023, Published online: 25 Jun 2023
 

Abstract

Blumea eriantha D.C is a weed from Asteraceae family and is reported to have anticancer activity. The essential oil from the aerial parts was extracted by steam distillation method with the yield of 0.36%. Through GC-MS analysis of the oil, seventeen compounds could be identified by comparing with linear retention indices with the library. Out of the seventeen compounds β-Caryophylline oxide was isolated by column chromatography with gradient elution and the structure was determined through FT-IR, MS, 1HNMR, 13 C NMR and DEPT. The oil was evaluated for its effect on angiogenesis using Chorioallantoic Membrane Assay (CAM Assay). The concentration dependent antiangiogenic effect was observed with IC 50 value of 19.28 ppm.

Graphical Abstract

Acknowledgements

The authors are grateful to the Department of Clinical Pharmacology, T.N. Medical College & B.Y.L. Nair Charitable Hospital, Mumbai, India, for helping and utilizing their laboratory facilities to carry out CAM assay.

Disclosure statement

This is to state that the authors do not have any conflict of interests.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.